Nektar Therapeutics - PE Ratio

The PE Ratio as of June 2026 (TTM) for Nektar Therapeutics (NKTR) is -7.69

According to Nektar Therapeutics’s latest financial reports and current stock price. The company's current PE Ratio is -7.69. This represents a change of 20.07% compared to the average of -6.40 of the last 4 quarters.

Nektar Therapeutics (NKTR) Historical PE Ratio (quarterly & annually)

How has NKTR PE Ratio performed in the past?

The mean historical PE Ratio of Nektar Therapeutics over the last ten years is -12.64. The current -7.69 PE Ratio has changed 5.98% with respect to the historical average. Over the past ten years (40 quarters), NKTR's PE Ratio was at its highest in in the September 2017 quarter at 15.38. The PE Ratio was at its lowest in in the December 2017 quarter at -71.10.

Nektar Therapeutics (NKTR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Nektar Therapeutics PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nektar Therapeutics (NKTR) Average PE Ratio

How has NKTR PE Ratio performed in the past?

The current PE Ratio of Nektar Therapeutics (NKTR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Nektar Therapeutics (NKTR) PE Ratio vs. Peers

How is NKTR’s PE Ratio compared to its peers?

Nektar Therapeutics’s PE Ratio is greater than Inhibrx Biosciences, Inc. (-11.09), less than Atai Beckley Inc. (-1.35), greater than Enliven Therapeutics, Inc. (-27.50), less than Syndax Pharmaceuticals, Inc. (-6.79), less than ORIC Pharmaceuticals, Inc. (-5.90), greater than Relay Therapeutics, Inc. (-10.11), less than Xencor, Inc. (-5.52), less than Immatics N.V. (-4.98), greater than Amylyx Pharmaceuticals, Inc. (-10.59), less than Sana Biotechnology, Inc. (-3.39),

Build a custom stock screener for Nektar Therapeutics (NKTR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nektar Therapeutics using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nektar Therapeutics (NKTR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nektar Therapeutics or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.